| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Letters to the Editor |
Head, Unit on Genetics & Endocrinology (UGEN) Developmental Endocrinology Branch, NICHD, NIH Bethesda, Maryland 20892
The data presented by Cetta et al. support our hypothesis that tissue-specific conditions may determine the need for loss-of-heterozygosity (LOH) of tumor-suppressor genes in the process of oncogenesis (1). Mechanisms that may make LOH unnecessary include inactivating mutations of the normal allele and other genomic rearrangements [which would not be identifiable by simple polymerase chain reaction (PCR)-allelotyping] and tissue-specific imprinting, which has recently been demonstrated to occur in such genes as Gsa, IGF-II, and KVLQT-1 (2, 3, 4). In addition, the classic separation between oncogenes and tumor-suppressor genes may not apply in complex pathways leading to oncogenesis (5). Finally, as we pointed out and Cetta et al. underlined, a particular mutation in a tumor-suppressor gene may act in a dominant manner. This is certainly true for dominant negative effects (6) and, perhaps, for the presence of modifier genes, whose expression is tissue-dependent.
Thus, we agree with Cetta et al. that their (and, perhaps, our) findings support this hypothesis. However, one should be cautious in interpreting LOH data from various tissues. Normal cells are almost always there to "contaminate" tumor DNA, unless methods such as laser-guided microdissection and single-cell PCR have been used. This is particularly important for lesions in which only a small proportion of tumor cells may demonstrate LOH. With this caveat in mind, we thank Dr. Cetta and his coworkers for supporting our hypothesis; clearly more work needs to be done in the clarification of the processes of endocrine oncogenesis.
Footnotes
Address correspondence to: Constantine A. Stratakis, M.D., D.Sc., Head, Unit on Genetics & Endocrinology (UGEN), Developmental Endocrinology Branch, National Institute on Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive, MSC-1862, Bethesda, Maryland 20892-1862.
Received January 8, 1999.
References
) knockout mice is due to tissue-specific
imprinting of the gsalpha gene. Proc Natl Acad Sci USA. 95:87158720.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |